Tony Coles, Yumanity Therapeutics CEO and former Onyx Pharma CEO, discusses the impact of Merck CEO Ken Frazier's leaving President Trump's Manufacturing Council. CNBC's Meg Tirrell weighs in.
CNBC's Meg Tirrell reports on President Trump's attacks on Merck's CEO Ken Frazier after he left the WH Manufacturing Council.
The president may want to check his facts on Merck, which he accused of "taking jobs out of the U.S."
CNBC's Meg Tirrell reports on Bristol-Myers falling after its kidney cancer drug trial results. Also, more on Merck's CEO's decision to leave the President's manufacturing council.
After Merck CEO Ken Frazier announced his resignation from the president's manufacturing council, CNBC's Meg Tirrell reports on Frazier's previous fights for justice.
Frazier said the experience showed him "why there can be no fair and consistent application of the death penalty under the current system."
CNBC's Meg Tirrell reports on the resignation of Merck CEO Ken Frazier from the president's White House council.
CNBC's Meg Tirrell discusses the biotech sector's worst day since January and what is driving the dip. The “Fast Money” traders weigh in.
CNBC's Meg Tirrell speaks with Chip Davis, Association for Accessible Medicines president, about generic drugs facing pricing pressures.
CNBC's Meg Tirrell reports Mylan shares are under pressure after reporting weaker than expected earnings.